LYKALABS

HealthcareBiotechnologyMicro Cap
Lyka Labs Limited

Lyka Labs Limited (LYKALABS) is a pharmaceutical company in the Biotechnology sub-sector of Healthcare. It develops, manufactures, and markets pharmaceutical formulations and activ...

हिन्दी में

Lyka Labs Limited (LYKALABS) स्वास्थ्य सेवा के बायोटेक्नोलॉजी उप-क्षेत्र में एक फार्मास्युटिकल कंपनी है। यह भारत में फार्मास्युटिकल फॉर्मूलेशन और एक्टिव फार्मास्युटिकल इंग्रीडिएंट्...

₹72.65-0.04%1D
Previous trading day close · Data updates after market close
1W: -6.2%
1M: -12.6%
6M: +25.2%
1Y: -25.6%
46/100
Below AvgResearch Score
Market Cap
₹258 Cr
Micro Cap
P/E Ratio
-25.72
Negative earnings
P/B Ratio
2.47
Reasonable
ROE
9.2%
Weak
ROCE
-6.7%
Average
Debt / Equity
0.36
Low debt
Div. Yield
N/A
EV/EBITDA
N/A
52W Low: ₹44.1Current: ₹72.6552W High: ₹100.94
At 50% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
36/100
Growth
Revenue, EPS, profit growth
52/100
Valuation
PE, PB, EV/EBITDA vs sector
48/100
Risk
Debt levels, volatility, coverage
53/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-25.72(Negative earnings)
Forward P/E
N/A
P/B Ratio
2.47(Reasonable)
P/S Ratio
1.96(Good)
EV/EBITDA
N/A
Dividend Yield
N/A
5Y CAGR
3.3%(Moderate)
Revenue Growth
-6.2%(Moderate)
Profitability
ROE
9.2%(Average)
ROCE
-6.7%(Average)
ROA
4.8%(Average)
Net Margin
-7.6%(Low)
EBITDA Margin
-0.1%
Financial Health
Debt to Equity
0.36(Low debt)
Current Ratio
1.45(Tight)
Quick Ratio
1.18(Good)
Interest Coverage
-2.73x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
23(Oversold)
RSI Exp (14)
5(Oversold)
MACD
-0.613(Bearish)
MACD Signal
1.252
BB Position
3%(Lower band)
BB Width
22.77%(High volatility)
ADX (14)
34.4(Strong trend)
Williams %R
-87.7(Oversold)
MFI (14)
59(Neutral)
CCI (20)
-176(Oversold)
Stoch %K
12(Oversold)
ATR (14)
2.26(Avg True Range)
OBV (M)
2.4(Positive)
1W OBV Chg
-5.2%(Decreasing)
Rel Volume
1.38x(Normal)
Volatility
42.8%(High)
Max DD 1Y
-74.0%(High loss)
EMA 200
74.6
EMA 50
76.4
SMA 200
67.9
vs SMA 50
-3.7%(Below SMA50)
vs SMA 200
7.0%(Above SMA200)
Volume
25.3K
Avg Vol 3M
0.2L
Shareholding Pattern
Promoter
58.2%
High confidence
FII
0.3%
DII / MF
0.7%
Share LYKALABS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.
Lyka Labs Limited (LYKALABS) Share Price ₹72.65 Today | StockSage Pro